IFP Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.7K | Buy |
537
+288
| +116% | +$29.8K | ﹤0.01% | 2305 |
|
|
2026
Q1 | $25.9K | Sell |
249
-81
| -25% | -$8.63K | ﹤0.01% | 2642 |
|
|
2025
Q4 | $34K | Sell |
330
-108
| -25% | -$10.5K | ﹤0.01% | 2414 |
|
|
2025
Q3 | $39.6K | Buy |
438
+153
| +54% | +$13.4K | ﹤0.01% | 2196 |
|
|
2025
Q2 | $25.1K | Hold |
285
| – | – | ﹤0.01% | 2419 |
|
|
2025
Q1 | $26K | Hold |
285
| – | – | ﹤0.01% | 2186 |
|
|
2024
Q4 | $24.6K | Hold |
285
| – | – | ﹤0.01% | 2152 |
|
|
2024
Q3 | $27.1K | Sell |
285
-22
| -7% | -$2.09K | ﹤0.01% | 2018 |
|
|
2024
Q2 | $28.1K | Hold |
307
| – | – | ﹤0.01% | 1922 |
|
|
2024
Q1 | $27.8K | Hold |
307
| – | – | ﹤0.01% | 1827 |
|
|
2023
Q4 | $25K | Buy |
307
+91
| +42% | +$7.14K | ﹤0.01% | 1824 |
|
|
2023
Q3 | $17.2K | Hold |
216
| – | – | ﹤0.01% | 2008 |
|
|
2023
Q2 | $17K | Sell |
216
-36
| -14% | -$2.82K | ﹤0.01% | 2090 |
|
|
2023
Q1 | $14.7K | Sell |
252
-79
| -24% | -$6.09K | ﹤0.01% | 2142 |
|
|
2022
Q4 | $33K | Sell |
331
-436
| -57% | -$32.2K | ﹤0.01% | 2535 |
|
|
2022
Q3 | $60K | Sell |
767
-122
| -14% | -$8.99K | ﹤0.01% | 2238 |
|
|
2022
Q2 | $58K | Hold |
889
| – | – | ﹤0.01% | 2059 |
|
|
2022
Q1 | $58K | Buy |
889
+663
| +293% | +$50.7K | ﹤0.01% | 2059 |
|
|
2021
Q4 | $20K | Sell |
226
-8
| -3% | -$595 | ﹤0.01% | 1946 |
|
|
2021
Q3 | $21K | Buy |
234
+11
| +5% | +$820 | ﹤0.01% | 1961 |
|
|
2021
Q2 | $16K | Sell |
223
-1
| -0.4% | -$71 | ﹤0.01% | 2038 |
|
|
2021
Q1 | $16K | Hold |
224
| – | – | ﹤0.01% | 1948 |
|
|
2020
Q4 | $15K | Sell |
224
-23
| -9% | -$1.47K | ﹤0.01% | 1909 |
|
|
2020
Q3 | $13K | Buy |
247
+1
| +0.4% | +$63 | ﹤0.01% | 1812 |
|
|
2020
Q2 | $13K | Sell |
246
-392
| -61% | -$23.7K | ﹤0.01% | 1734 |
|
|
2020
Q1 | $33K | Buy |
638
+18
| +3% | +$1.11K | ﹤0.01% | 1297 |
|
|
2019
Q4 | $40K | Buy |
+620
| New | +$37.4K | ﹤0.01% | 1349 |
|
|
2018
Q4 | – | Sell |
-150
| Closed | -$10K | – | 3790 |
|
|
2018
Q3 | $10K | Hold |
150
| – | – | ﹤0.01% | 2860 |
|
|
2018
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 2975 |
|
|
2018
Q1 | $9K | Hold |
150
| – | – | ﹤0.01% | 2853 |
|
|
2017
Q4 | $9K | Hold |
150
| – | – | ﹤0.01% | 2898 |
|
|
2017
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 3089 |
|
|
2017
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 3100 |
|
|
2017
Q1 | $8K | Hold |
150
| – | – | ﹤0.01% | 3055 |
|
|
2016
Q4 | $8K | Hold |
150
| – | – | ﹤0.01% | 3051 |
|
|
2016
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 2906 |
|
|
2016
Q2 | $9K | Buy |
+150
| New | +$8.74K | ﹤0.01% | 2807 |
|
|
2016
Q1 | – | Sell |
-150
| Closed | -$10K | – | 3162 |
|
|
2015
Q4 | $10K | Buy |
+150
| New | +$9.69K | ﹤0.01% | 2585 |
|
Other funds holding PPH
JSAM
AT
AWC
IFP Advisors's PPH Position: Q2 2026 in Review
IFP Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 116% in Q2 2026, buying an estimated $29.8K and bringing the position to 537 shares worth $58.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2305.
IFP Advisors first reported a position in PPH in Q4 2015 and has held it in 38 quarters since. The position peaked at $60K in Q3 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- IFP Advisors held 537 shares of VanEck Pharmaceutical ETF worth $58.7K as of Q2 2026.
- IFP Advisors bought 288 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $29.8K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2305 holding.
- IFP Advisors first reported a position in VanEck Pharmaceutical ETF in Q4 2015 and has held it in 38 quarters since.
- IFP Advisors's VanEck Pharmaceutical ETF position peaked at $60K in Q3 2022.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.